Eye Allergy Treatment Market Research Report - Forecast till 2027

Eye Allergy Treatment Market Application And Share Analysis By Type (Vernal Keratoconjunctivitis, Atopic Keratoconjunctivitis, & Contact Allergic Conjunctivitis), Treatment (Medications & Allergy Shots), And End User (Hospitals & Clinics)-Forecast Till 2027

ID: MRFR/Pharma/2523-CR | April, 2019 | Region : Global

1 Report Prologue

2 Introduction
2.1 Definition 17
2.2 Scope of the Study 17
2.3 List of Assumptions 18
2.4 Market Structure 18
3 Research Methodology
3.1 Research Process 20
3.2 Primary Research 21
3.3 Secondary Research 22
3.4 Market Size Estimation 23
3.5 Forecast Model 23
4 Market Dynamics
4.1 Introduction 25
4.2 Drivers 26
4.2.1 Increasing prevalence of ophthalmological disorders 26
4.2.2 Favorable government funding 26
4.2.3 Product advancements 26
4.3 Restraints 27
4.3.1 Lack of awareness 27
4.3.2 Side-effects of certain eye allergy treatments 27
4.4 Opportunity 27
4.4.1 Emerging markets of eye allergy treatment 27
4.5 Mega Trends 28
4.5.1 Technological Trends 28
4.6 Macroeconomics 28
5 Market Factor Analysis
5.1 Porter’s Five Forces Analysis 30
5.1.1 Bargaining Power of Suppliers 30
5.1.2 Bargaining Power of Buyers 30
5.1.3 Threat of New Entrants 31
5.1.4 Threat of Substitutes 31
5.1.5 Intensity of Rivalry 31
5.2 Investment Opportunity Analysis 31
5.3 Pricing Analysis 31
5.4 Demand & Supply: Gap Analysis 32
5.5 Merger and Acquisition Landscape 32
5.6 Value Chain Analysis 32
5.6.1 R&D 33
5.6.2 Manufacturing 33
5.6.3 Distribution & Sales 33
5.6.4 Post-Sales Monitoring 33
6 Eye Allergy Treatment Market, by Type
6.1 Introduction 35
6.2 Seasonal and Perennial Allergic Conjunctivitis 36
6.3 Vernal Keratoconjunctivitis 37
6.4 Atopic Keratoconjunctivitis 37
6.5 Contact Allergic Conjunctivitis 38
6.6 Giant Papillary Conjunctivitis 38
7 Eye Allergy Treatment Market, by Treatment
7.1 Introduction 40
7.2 Medications 41
7.2.1 Artificial Tears 43
7.2.2 Decongestants 43
7.2.3 Antihistamine/Mast-Cell Stabilizers 44
7.2.4 Oral Antihistamines 44
7.2.5 Corticosteroids 45
7.3 ALLERGY SHOTS (Immunotherapy) 46
7.3.1 Subcutaneous Immunotherapy Treatment (SCIT) 47
7.3.2 Sublingual Immunotherapy Treatment (SLIT) 48
8 Eye Allergy Treatment Market, by End User
8.1 Introduction 50
8.2 Hospitals and Clinics 51
8.3 Specialty Centers 51
9 Global Eye Allergy Treatment Market, by Region
9.1 Introduction 53
9.2 Americas 55
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.2.1 North America 58
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.2.1.1 US 62
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.2.1.2 Canada 64
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.2.2 Latin America 67
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.3 Europe 70
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.3.1 Western Europe 73
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.3.1.1 Germany 77
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.3.1.2 France 79
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.3.1.3 UK 82
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.3.1.4 Italy 84
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.3.1.5 Spain 87
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.3.1.6 Rest of Western Europe 89
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.3.2 Eastern Europe 92
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.4 Asia-Pacific 95
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.4.1 Japan 98
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.4.2 China 101
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.4.3 India 103
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.4.4 Australia 106
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.4.5 South Korea 108
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.4.6 Rest of Asia-Pacific 111
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.5 Middle East and Africa 114
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.5.1 Middle East 117
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.5.1.1 Saudi Arabia 121
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.5.1.2 UAE 123
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.5.1.3 Egypt 126
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.5.1.4 Rest of Middle East 128
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
9.5.2 Africa 131
Eye Allergy Treatment Market, by Type
Eye Allergy Treatment Market, by Treatment
Eye Allergy Treatment Market, by End User
10 Company Landscape
10.1 Company Share Analysis 135
11 Company Profile
11.1 Allergan Plc 138
11.1.1 Company Overview 138
11.1.2 Financial Overview 138
11.1.3 Products/Services Offered 139
11.1.4 Key Developments 139
11.1.5 SWOT Analysis 139
11.1.6 Key Strategies 139
11.2 Johnson & Johnson Services Inc. 140
11.2.1 Company Overview 140
11.2.2 Financial Overview 140
11.2.3 Products/Services Offered 141
11.2.4 Key Developments 141
11.2.5 SWOT Analysis 141
11.2.6 Key Strategies 141
11.3 Novartis AG 142
11.3.1 Company Overview 142
11.3.2 Financial Overview 142
11.3.3 Products/Services Offered 143
11.3.4 Key Developments 143
11.3.5 SWOT Analysis 143
11.3.6 Key Strategies 143
11.4 Bausch Health (Valeant Pharmaceuticals International Inc.) 144
11.4.1 Company Overview 144
11.4.2 Financial Overview (Valeant Pharmaceuticals International Inc.) 144
11.4.3 Products/Services Offered 145
11.4.4 SWOT Analysis 145
11.4.5 Key Developments 145
11.4.6 Key Strategies 145
11.5 Santen Pharmaceutical Co. Ltd 146
11.5.1 Company Overview 146
11.5.2 Financial Overview 146
11.5.3 Products/Services Offered 147
11.5.4 SWOT Analysis 147
11.5.5 Key Developments 147
11.5.6 Key Strategies 147
11.6 Teva Pharmaceutical Industries Ltd 148
11.6.1 Company Overview 148
11.6.2 Financial Overview 148
11.6.3 Products/Services Offered 149
11.6.4 Key Developments 149
11.6.5 SWOT Analysis 149
11.6.6 Key Strategies 149
11.7 Nicox 150
11.7.1 Company Overview 150
11.7.2 Financial Overview 150
11.7.3 Products/Services Offered 150
11.7.4 SWOT Analysis 150
11.7.5 Key Developments 150
11.7.6 Key Strategies 150
11.8 Akorn Inc. 151
11.8.1 Company Overview 151
11.8.2 Financial Overview 151
11.8.3 Products/Services Offered 152
11.8.4 SWOT Analysis 152
11.8.5 Key Developments 152
11.8.6 Key Strategies 152
11.9 Shire 153
11.9.1 Company Overview 153
11.9.2 Financial Overview 153
11.9.3 Products/Services Offered 154
11.9.4 SWOT Analysis 154
11.9.5 Key Developments 154
11.9.6 Key Strategies 154
11.10 Nutra Essential OTC 155
11.10.1 Company Overview 155
11.10.2 Financial Overview 155
11.10.3 Products/Services Offered 155
11.10.4 SWOT Analysis 155
11.10.5 Key Developments 155
11.10.6 Key Strategies 155
12 Appendix
12.1 Discussion Blueprint 157
12.2 References 158

13 List of Tables
TABLE 1 LIST OF ASSUMPTIONS 18
TABLE 2 GLOBAL EYE ALLERGY TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 36
TABLE 3 GLOBAL EYE ALLERGY TREATMENT MARKET FOR SEASONAL AND PERENNIAL ALLERGIC CONJUNCTIVITIS, BY REGION,
2020–2027 (USD MILLION) 36
TABLE 4 GLOBAL EYE ALLERGY TREATMENT MARKET FOR VERNAL KERATOCONJUNCTIVITIS, BY REGION, 2020–2027 (USD MILLION) 37
TABLE 5 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ATOPIC KERATOCONJUNCTIVITIS, BY REGION, 2020–2027 (USD MILLION) 37
TABLE 6 GLOBAL EYE ALLERGY TREATMENT MARKET FOR CONTACT ALLERGIC CONJUNCTIVITIS, BY REGION,
2020–2027 (USD MILLION) 38
TABLE 7 GLOBAL EYE ALLERGY TREATMENT MARKET FOR GIANT PAPILLARY CONJUNCTIVITIS, BY REGION, 2020–2027 (USD MILLION) 38
TABLE 8 GLOBAL EYE ALLERGY TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 41
TABLE 9 GLOBAL EYE ALLERGY TREATMENT MARKET FOR MEDICATIONS, BY TYPE, 2020–2027 (USD MILLION) 42
TABLE 10 GLOBAL EYE ALLERGY TREATMENT MARKET FOR MEDICATIONS, BY REGION, 2020–2027 (USD MILLION) 42
TABLE 11 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ARTIFICIAL TEARS, BY REGION, 2020–2027 (USD MILLION) 43
TABLE 12 GLOBAL EYE ALLERGY TREATMENT MARKET FOR DECONGESTANTS, BY REGION, 2020–2027 (USD MILLION) 43
TABLE 13 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ANTIHISTAMINE/MAST-CELL STABILIZERS, BY REGION,
2020–2027 (USD MILLION) 44
TABLE 14 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ORAL ANTIHISTAMINES, BY REGION, 2020–2027 (USD MILLION) 44
TABLE 15 GLOBAL EYE ALLERGY TREATMENT MARKET FOR CORTICOSTEROIDS, BY REGION, 2020–2027 (USD MILLION) 45
TABLE 16 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020–2027 (USD MILLION) 46
TABLE 17 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY REGION,
2020–2027 (USD MILLION) 47
TABLE 18 GLOBAL EYE ALLERGY TREATMENT MARKET FOR SUBCUTANEOUS IMMUNOTHERAPY TREATMENT (SCIT), BY REGION,
2020–2027 (USD MILLION) 47
TABLE 19 GLOBAL EYE ALLERGY TREATMENT MARKET FOR SUBLINGUAL IMMUNOTHERAPY TREATMENT (SLIT), BY REGION,
2020–2027 (USD MILLION) 48
TABLE 20 GLOBAL EYE ALLERGY TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 50
TABLE 21 GLOBAL EYE ALLERGY TREATMENT MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020–2027 (USD MILLION) 51
TABLE 22 GLOBAL EYE ALLERGY TREATMENT MARKET FOR SPECIALTY CENTERSS, BY REGION, 2020–2027 (USD MILLION) 51
TABLE 23 GLOBAL EYE ALLERGY TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 54
TABLE 24 AMERICAS: EYE ALLERGY TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 55
TABLE 25 AMERICAS: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 56
TABLE 26 AMERICAS: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 56
TABLE 27 AMERICAS: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 57
TABLE 28 AMERICAS: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,
2020-2027 (USD MILLION) 57
TABLE 29 AMERICAS: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 58
TABLE 30 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 59
TABLE 31 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 59
TABLE 32 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 60
TABLE 33 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 60
TABLE 34 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,
2020-2027 (USD MILLION) 61
TABLE 35 NORTH AMERICA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 61
TABLE 36 US: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 62
TABLE 37 US: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 62
TABLE 38 US: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 63
TABLE 39 US: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 63
TABLE 40 US: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 64
TABLE 41 CANADA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 64
TABLE 42 CANADA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 65
TABLE 43 CANADA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 65
TABLE 44 CANADA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 66
TABLE 45 CANADA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 66
TABLE 46 LATIN AMERICA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 67
TABLE 47 LATIN AMERICA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 67
TABLE 48 LATIN AMERICA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 68
TABLE 49 LATIN AMERICA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,
2020-2027 (USD MILLION) 68
TABLE 50 LATIN AMERICA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 69
TABLE 51 EUROPE: EYE ALLERGY TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 70
TABLE 52 EUROPE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 71
TABLE 53 EUROPE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 71
TABLE 54 EUROPE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 72
TABLE 55 EUROPE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 72
TABLE 56 EUROPE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 73
TABLE 57 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 74
TABLE 58 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 74
TABLE 59 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 75
TABLE 60 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 75
TABLE 61 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,
2020-2027 (USD MILLION) 76
TABLE 62 WESTERN EUROPE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 76
TABLE 63 GERMANY: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 77
TABLE 64 GERMANY: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 77
TABLE 65 GERMANY: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 78
TABLE 66 GERMANY: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,
2020-2027 (USD MILLION) 78
TABLE 67 GERMANY: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 79
TABLE 68 FRANCE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 79
TABLE 69 FRANCE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 80
TABLE 70 FRANCE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 80
TABLE 71 FRANCE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 81
TABLE 72 FRANCE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 81
TABLE 73 UK: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 82
TABLE 74 UK: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 82
TABLE 75 UK: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 83
TABLE 76 UK: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 83
TABLE 77 UK: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 84
TABLE 78 ITALY: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 84
TABLE 79 ITALY: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 85
TABLE 80 ITALY: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 85
TABLE 81 ITALY: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 86
TABLE 82 ITALY: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 86
TABLE 83 SPAIN: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 87
TABLE 84 SPAIN: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 87
TABLE 85 SPAIN: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 88
TABLE 86 SPAIN: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 88
TABLE 87 SPAIN: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 89
TABLE 88 REST OF WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 89
TABLE 89 REST OF WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 90
TABLE 90 REST OF WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 90
TABLE 91 REST OF WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,
2020-2027 (USD MILLION) 91
TABLE 92 REST OF WESTERN EUROPE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 91
TABLE 93 EASTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 92
TABLE 94 EASTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 92
TABLE 95 EASTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 93
TABLE 96 EASTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,
2020-2027 (USD MILLION) 93
TABLE 97 EASTERN EUROPE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 94
TABLE 98 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95
TABLE 99 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 96
TABLE 100 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 96
TABLE 101 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 97
TABLE 102 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,
2020-2027 (USD MILLION) 97
TABLE 103 ASIA-PACIFIC: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 98
TABLE 104 JAPAN: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 98
TABLE 105 JAPAN: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 99
TABLE 106 JAPAN: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 99
TABLE 107 JAPAN: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 100
TABLE 108 JAPAN: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 100
TABLE 109 CHINA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 101
TABLE 110 CHINA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 101
TABLE 111 CHINA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 102
TABLE 112 CHINA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 102
TABLE 113 CHINA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 103
TABLE 114 INDIA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 103
TABLE 115 INDIA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 104
TABLE 116 INDIA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 104
TABLE 117 INDIA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 105
TABLE 118 INDIA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 105
TABLE 119 AUSTRALIA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 106
TABLE 120 AUSTRALIA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 106
TABLE 121 AUSTRALIA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 107
TABLE 122 AUSTRALIA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 107
TABLE 123 AUSTRALIA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 108
TABLE 124 SOUTH KOREA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 108
TABLE 125 SOUTH KOREA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 109
TABLE 126 SOUTH KOREA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 109
TABLE 127 SOUTH KOREA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,
2020-2027 (USD MILLION) 110
TABLE 128 SOUTH KOREA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 110
TABLE 129 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 111
TABLE 130 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 111
TABLE 131 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 112
TABLE 132 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,
2020-2027 (USD MILLION) 112
TABLE 133 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 113
TABLE 134 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 114
TABLE 135 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 115
TABLE 136 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 115
TABLE 137 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 116
TABLE 138 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,
2020-2027 (USD MILLION) 116
TABLE 139 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 117
TABLE 140 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 118
TABLE 141 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 118
TABLE 142 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 119
TABLE 143 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 119
TABLE 144 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,
2020-2027 (USD MILLION) 120
TABLE 145 MIDDLE EAST: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 120
TABLE 146 SAUDI ARABIA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 121
TABLE 147 SAUDI ARABIA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 121
TABLE 148 SAUDI ARABIA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 122
TABLE 149 SAUDI ARABIA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,
2020-2027 (USD MILLION) 122
TABLE 150 SAUDI ARABIA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 123
TABLE 151 UAE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 123
TABLE 152 UAE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 124
TABLE 153 UAE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 124
TABLE 154 UAE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 125
TABLE 155 UAE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 125
TABLE 156 EGYPT: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 126
TABLE 157 EGYPT: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 126
TABLE 158 EGYPT: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 127
TABLE 159 EGYPT: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 127
TABLE 160 EGYPT: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 128
TABLE 161 REST OF MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 128
TABLE 162 REST OF MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 129
TABLE 163 REST OF MIDDLE EAST: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 129
TABLE 164 REST OF MIDDLE EAST: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,
2020-2027 (USD MILLION) 130
TABLE 165 REST OF MIDDLE EAST: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 130
TABLE 166 AFRICA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 131
TABLE 167 AFRICA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 131
TABLE 168 AFRICA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 132
TABLE 169 AFRICA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 132
TABLE 170 AFRICA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 133


14 List of Figures
FIGURE 1 GLOBAL EYE ALLERGY TREATMENT MARKET: MARKET STRUCTURE 18
FIGURE 2 RESEARCH PROCESS OF MRFR 20
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACHES 23
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL EYE ALLERGY TREATMENT MARKET 25
FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL EYE ALLERGY TREATMENT MARKET 30
FIGURE 6 VALUE CHAIN - GLOBAL EYE ALLERGY TREATMENT MARKET 32
FIGURE 7 GLOBAL EYE ALLERGY TREATMENT MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 35
FIGURE 8 GLOBAL EYE ALLERGY TREATMENT MARKET, BY TREATMENT, 2020 & 2027 (USD MILLION) 40
FIGURE 9 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR MEDICATIONS, BY TYPE, 2020 & 2027 (USD MILLION) 41
FIGURE 10 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,
2020 & 2027 (USD MILLION) 46
FIGURE 11 GLOBAL EYE ALLERGY TREATMENT MARKET, BY END USER, 2020 & 2027 (USD MILLION) 50
FIGURE 12 GLOBAL EYE ALLERGY TREATMENT MARKET, BY REGION, 2020 & 2027 (USD MILLION) 54
FIGURE 13 AMERICAS: EYE ALLERGY TREATMENT MARKET SHARE, BY REGION,2020 (%) 55
FIGURE 14 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET SHARE, BY COUNTRY,2020 (%) 58
FIGURE 15 EUROPE: EYE ALLERGY TREATMENT MARKET SHARE, BY REGION,2020 (%) 70
FIGURE 16 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET SHARE, BY COUNTRY,2020 (%) 73
FIGURE 17 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET SHARE, BY COUNTRY,2020 (%) 95
FIGURE 18 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET SHARE, BY REGION,2020 (%) 114
FIGURE 19 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET SHARE, BY COUNTRY,2020 (%) 117
FIGURE 20 GLOBAL EYE ALLERGY TREATMENT MARKET, COMPANY SHARE ANALYSIS, 2020 135

Eye Allergy Treatment Market Speak to Analyst Request a Free Sample